XORTX Therapeutics PEG Ratio

XORTX Therapeutics (XRTX) currently reports a PEG ratio of -1.31. That is below the Materials sector average of 10.15. Use the charts on this page to explore XORTX Therapeutics's PEG ratio history and peer comparisons.

XORTX Therapeutics's PEG ratio of -1.31 is lower than the Materials sector average of 10.15. That is roughly 112.9% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

The PEG ratio is a valuation multiple that relates XORTX Therapeutics's market price to a fundamental measure such as earnings, sales, or book value. At -1.31, XRTX can look expensive or cheap only in context — versus its own history, growth rate, and Materials peers. Higher multiples often price in stronger expected growth; lower ones can signal value or concern.

Start with the current PEG ratio of -1.31, then check the historical chart for trend and the peer comparison chart for relative positioning. The Materials average is 10.15. From there, open related valuation or income-statement pages for XORTX Therapeutics, and consider following XRTX for alerts when major investors trade the stock.

XORTX Therapeutics is classified in the Materials sector. On PEG ratio, it currently shows -1.31 versus a sector average near 10.15. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Materials are usually more informative than comparing XRTX with unrelated industries.